chr11-6402145-G-C
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4_StrongBS2_Supporting
The NM_001164.5(APBB1):āc.1319C>Gā(p.Ala440Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000211 in 1,614,110 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001164.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
APBB1 | NM_001164.5 | c.1319C>G | p.Ala440Gly | missense_variant | 8/15 | ENST00000609360.6 | NP_001155.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
APBB1 | ENST00000609360.6 | c.1319C>G | p.Ala440Gly | missense_variant | 8/15 | 5 | NM_001164.5 | ENSP00000477213 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152182Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000115 AC: 29AN: 251308Hom.: 1 AF XY: 0.0000884 AC XY: 12AN XY: 135816
GnomAD4 exome AF: 0.0000205 AC: 30AN: 1461810Hom.: 1 Cov.: 32 AF XY: 0.0000179 AC XY: 13AN XY: 727206
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152300Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74454
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 15, 2021 | The c.1319C>G (p.A440G) alteration is located in exon 8 (coding exon 7) of the APBB1 gene. This alteration results from a C to G substitution at nucleotide position 1319, causing the alanine (A) at amino acid position 440 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at